Analyst Reco. Penumbra, Inc.

Equities

PEN

US70975L1070

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
204.4 ^USD	-0.53%		+0.69%	-18.74%

Apr. 23	Penumbra, Inc. Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots	CI
Apr. 17	DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Truist Securities Cuts Penumbra's Price Target to $280 From $290, Keeps Buy Rating	Mar. 22	MT
Piper Sandler Adjusts Price Target on Penumbra to $290 From $310, Maintains Overweight Rating	Feb. 26	MT
Deutsche Bank Raises Penumbra Price Target to $288 From $257, Maintains Buy Rating	Feb. 23	MT
Truist Securities Cuts Price Target on Penumbra to $290 From $300, Maintains Buy Rating	Feb. 23	MT
JPMorgan Downgrades Penumbra to Neutral From Overweight, Cuts Price Target to $250 From $284	Feb. 23	MT
RBC Raises Price Target on Penumbra to $289 From $280, Keeps Outperform Rating	Jan. 12	MT
RBC Capital Adjusts Penumbra's Price Target to $280 From $248, Keeps Outperform Rating	Jan. 11	MT
Truist Securities Raises Price Target on Penumbra to $295 From $265, Maintains Buy Rating	Dec. 22	MT
Truist Adjusts Penumbra's Price Target to $265 From $240, Keeps Buy Rating	Dec. 12	MT
Deutsche Bank Cuts Penumbra Price Target to $257 From $367, Maintains Buy Rating	Nov. 03	MT
Morgan Stanley Cuts Price Target on Penumbra to $240 From $265, Maintains Equalweight Rating	Nov. 03	MT
Citigroup Cuts Price Target on Penumbra to $320 From $390, Maintains Buy Rating	23-10-02	MT
Morgan Stanley Initiates Coverage on Penumbra With Equal Weight Rating, $265 Price Target	23-09-06	MT
Wells Fargo Adjusts Price Target on Penumbra to $337 From $320, Maintains Overweight Rating	23-08-02	MT
Truist Securities Adjusts Price Target on Penumbra to $370 From $350, Maintains Buy Rating	23-07-19	MT
Baird Initiates Penumbra With Outperform Rating, $375 Price Target	23-07-19	MT
RBC Boosts Price Target on Penumbra to $349 From $303, Maintains Outperform Rating	23-07-12	MT
Citigroup Raises Price Target on Penumbra to $390 From $325, Maintains Buy Rating	23-07-11	MT
Deutsche Bank Raises Penumbra's Price Target to $376 From $325, Maintains Buy Rating	23-06-26	MT
BTIG Increases Price Target on Penumbra to $328 From $312, Maintains Buy Rating	23-06-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Penumbra, Inc. : The underdog in healthcare

April 11, 2024 at 09:39 pm EDT